Home
Genocea Biosciences

Genocea Biosciences Market Share Analysis for March 2026

Login Agen SBOBET Resmi 3DSBOBET. Nikmati Pasaran Bola ribuan liga, Mix Parlay Campuran, & Odds Asia Grade A. Menang berapapun Jaminan Bayar 100%.

Health > Biotechnology and Pharmaceuticals

Domaingenocea.com

Year Founded2006

Employees51 - 200

Annual Revenue$1M - $2M

Genocea Biosciences

Genocea Biosciences (including company regionals)

genocea.com

See more website traffic and engagement information

Genocea Biosciences Revenue up to March 2026 is 1M - 2M

revenue generated by Genocea Biosciences top domains

Genocea Biosciences top domains revenue over 3 years

Revenue for Genocea Biosciences top domains

genocea.com1M - 2M

See more with Sales Intelligence

Total visits to Genocea Biosciences's top domains

Understand Genocea Biosciences market share and potential market reach.

Total visits last 3 months

No Data to Display

Avg. visit duration in Genocea Biosciences's top domains

Analyze Genocea Biosciences engagement metrics.

Average visit duration last 3 months

No Data to Display

Avg. pageviews on Genocea Biosciences's top domains

See how Genocea Biosciences keep users engaged, nurture their interest, and encourage them to take the next step.

Average page views last 3 months

No Data to Display

Genocea Biosciences top competitors by domain

Top similar sites in March 2026, ranked by their affinity

vbivaccines.comCompany NameVBI VaccinesEmployees51 - 200HQUnited States, Massachusetts, CambridgeAnnual revenue< $1MTotal visits5.9KHealth > Biotechnology and Pharmaceuticals

Top technologies used by Genocea Biosciences

These are the website technologies, by industry, used by Genocea Biosciences top domains

Payment & Currencies (10)

Cart Functionality

eCommerce (7)

Squarespace Commerce

Social (7)

Google+ Platform

Mobile (4)

Meta Viewport

More Technologies

10

See all

News & Signals from Genocea Biosciences

With Similarweb Sales signals alerts, you’ll receive daily updates of recognized buying signals whenever new opportunities or threats arise in your target audience.

NewsDuvall left Genocea Biosciences, Inc. as CFO on Jan 1st '19.Ms. Duvall joins the company from Genocea, where she served as the CFO since 2019.

NewsGenocea Biosciences, Inc. launched TITAN study on Jul 13th '21.On 13 July 2021, Genocea Biosciences, Inc. announced in its TITAN study, which was the first dosing of GEN-011 therapy on its patient during phase 1/2a clinical trial testing.

NewsGenocea Biosciences, Inc. hired John Lunger as board of directors on Mar 7th '22.Genocea Biosciences, Inc. (Nasdaq: GNCA), a biopharmaceutical company developing next-generation neoantigen immunotherapies, today announced that John Lunger, Chief Patient Supply Officer at Adaptimmune Therapeutics plc ("Adaptimmune"), has joined its board of directors.